Hybio Pharmaceutical Co., Ltd. 300199.SZ Stock
Hybio Pharmaceutical Co., Ltd. Price Chart
Hybio Pharmaceutical Co., Ltd. 300199.SZ Financial and Trading Overview
| Hybio Pharmaceutical Co., Ltd. stock price | 12.29 CNY |
| Previous Close | 11.55 CNY |
| Open | 11.59 CNY |
| Bid | 11.59 CNY x 0 |
| Ask | 11.6 CNY x 0 |
| Day's Range | 11.46 - 11.8 CNY |
| 52 Week Range | 8.95 - 24.44 CNY |
| Volume | 31.1M CNY |
| Avg. Volume | 41.98M CNY |
| Market Cap | 10.65B CNY |
| Beta (5Y Monthly) | 0.765068 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.62 CNY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | April 19, 2018 |
| 1y Target Est | N/A |
300199.SZ Valuation Measures
| Enterprise Value | 11.95B CNY |
| Trailing P/E | N/A |
| Forward P/E | 15.917808 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 14.936736 |
| Price/Book (mrq) | 7.8940215 |
| Enterprise Value/Revenue | 16.754 |
| Enterprise Value/EBITDA | -119.683 |
Trading Information
Hybio Pharmaceutical Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.765068 |
| 52-Week Change | -7.22% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 24.44 CNY |
| 52 Week Low | 8.95 CNY |
| 50-Day Moving Average | 11.22 CNY |
| 200-Day Moving Average | 13.2 CNY |
300199.SZ Share Statistics
| Avg. Volume (3 month) | 41.98M CNY |
| Avg. Daily Volume (10-Days) | 46.04M CNY |
| Shares Outstanding | 883.24M |
| Float | 534M |
| Short Ratio | N/A |
| % Held by Insiders | 38.85% |
| % Held by Institutions | 1.80% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 20:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -41.25% |
| Operating Margin (ttm) | -31.28% |
| Gross Margin | 71.02% |
| EBITDA Margin | -13.99% |
Management Effectiveness
| Return on Assets (ttm) | -3.79% |
| Return on Equity (ttm) | -20.32% |
Income Statement
| Revenue (ttm) | 713.33M CNY |
| Revenue Per Share (ttm) | 0.82 CNY |
| Quarterly Revenue Growth (yoy) | 5.40% |
| Gross Profit (ttm) | 544.69M CNY |
| EBITDA | -99854056 CNY |
| Net Income Avi to Common (ttm) | -294289920 CNY |
| Diluted EPS (ttm) | -0.34 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 227.78M CNY |
| Total Cash Per Share (mrq) | 0.26 CNY |
| Total Debt (mrq) | 1.82B CNY |
| Total Debt/Equity (mrq) | 137.14 CNY |
| Current Ratio (mrq) | 0.621 |
| Book Value Per Share (mrq) | 1.472 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -42407692 CNY |
| Levered Free Cash Flow (ttm) | -267779056 CNY |
Profile of Hybio Pharmaceutical Co., Ltd.
| Country | China |
| State | N/A |
| City | Shenzhen |
| Address | Hanyu Biological Park, No. 37 |
| ZIP | 518057 |
| Phone | 86 755 2658 8000 |
| Website | https://www.hybio.com.cn |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 975 |
Hybio Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of therapeutic peptides API and polypeptide drugs in China and internationally. The company provides liraglutide, semaglutide and exenatide for diabetes; terlipressin, desmopressin and linaclotide for digestive tract and metabolic system; ganirelix, cetrorelix and atosiban for obstetrics and gynecology, etc; customized peptides; working standards for the peptide APIs and related impurities, to facilitate your project in an all-round way; CRO services; and platform for CDMO services, which includes peptide API synthesis and purification process development, finish dosage form development, reference standard preparation and qualification, impurity and product quality study and analysis, GMP system meeting EU and FDA standard, international and Chinese regulatory and dossier support, etc. Hybio Pharmaceutical Co., Ltd. was founded in 1998 and is headquartered in Shenzhen, China.
Q&A For Hybio Pharmaceutical Co., Ltd. Stock
What is a current 300199.SZ stock price?
Hybio Pharmaceutical Co., Ltd. 300199.SZ stock price today per share is 12.29 CNY.
How to purchase Hybio Pharmaceutical Co., Ltd. stock?
You can buy 300199.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hybio Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Hybio Pharmaceutical Co., Ltd. is 300199.SZ.
Which industry does the Hybio Pharmaceutical Co., Ltd. company belong to?
The Hybio Pharmaceutical Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Hybio Pharmaceutical Co., Ltd. have in circulation?
The max supply of Hybio Pharmaceutical Co., Ltd. shares is 883.24M.
What is Hybio Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Hybio Pharmaceutical Co., Ltd. PE Ratio is now.
What was Hybio Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Hybio Pharmaceutical Co., Ltd. EPS is -0.62 CNY over the trailing 12 months.
Which sector does the Hybio Pharmaceutical Co., Ltd. company belong to?
The Hybio Pharmaceutical Co., Ltd. sector is Healthcare.